BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35465865)

  • 21. Peripherally inserted central catheter-related bloodstream infections in patients with hematological malignancies: A retrospective 7-years single-center study.
    Gao T; Zhu X; Zeng Q; Li X; Luo M; Yu C; Hu L; He J; Li Y; Yang Z; Yang H; Huang X; Gu X; Liu Z
    Am J Infect Control; 2022 Oct; 50(10):1171-1177. PubMed ID: 35108580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dressings and securement devices for central venous catheters (CVC).
    Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010367. PubMed ID: 26358142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripherally inserted central catheter-associated bloodstream infection: Risk factors and the role of antibiotic-impregnated catheters for prevention.
    Kagan E; Salgado CD; Banks AL; Marculescu CE; Cantey JR
    Am J Infect Control; 2019 Feb; 47(2):191-195. PubMed ID: 30180989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices.
    Worth LJ; Seymour JF; Slavin MA
    Support Care Cancer; 2009 Jul; 17(7):811-8. PubMed ID: 19096883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A role for peripherally inserted central venous catheters in the prevention of catheter-related blood stream infections in patients with hematological malignancies.
    Sakai T; Kohda K; Konuma Y; Hiraoka Y; Ichikawa Y; Ono K; Horiguchi H; Tatekoshi A; Takada K; Iyama S; Kato J
    Int J Hematol; 2014 Dec; 100(6):592-8. PubMed ID: 25248408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catheter-related complications in onco-hematologic children: A retrospective clinical study on 227 central venous access devices.
    Annetta MG; Celentano D; Zumstein L; Attinà G; Ruggiero A; Conti G; Pittiruti M
    J Vasc Access; 2024 Mar; 25(2):512-518. PubMed ID: 36113076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catheter-related bloodstream infection associated with multiple insertions of the peripherally inserted central catheter in patients with hematological disorders.
    Hashimoto Y; Hosoda R; Omura H; Tanaka T
    Sci Rep; 2021 Jun; 11(1):12209. PubMed ID: 34108612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of Pediatric Central Venous Access Device Placement With Concomitant Surgical Procedures.
    Bludevich BM; Chandler NM; Gonzalez R; Danielson PD; Snyder CW
    J Surg Res; 2021 Mar; 259():451-457. PubMed ID: 33616076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies.
    Maki DG; Kluger DM; Crnich CJ
    Mayo Clin Proc; 2006 Sep; 81(9):1159-71. PubMed ID: 16970212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient and central venous catheter related risk factors for blood stream infections in children receiving chemotherapy.
    Yacobovich J; Ben-Ami T; Abdalla T; Tamary H; Goldstein G; Weintraub M; Yaniv I; Toren A; Kenet G; Revel-Vilk S
    Pediatr Blood Cancer; 2015 Mar; 62(3):471-6. PubMed ID: 25327811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric Central Venous Access Device Lock Solutions: A Network Meta-analysis.
    Takashima M; Ezure Y; Furuya-Kanamori L; Wolf J; Dufficy M; Gibson V; Clark J; Ullman A
    Pediatrics; 2024 Jan; 153(2):. PubMed ID: 38287882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.
    McKeown C; Ricciuti A; Agha M; Raptis A; Hou JZ; Farah R; Redner RL; Im A; Dorritie KA; Sehgal A; Rossetti J; Lontos K; Bovbjerg DH; Normolle D; Boyiadzis M
    Support Care Cancer; 2022 Feb; 30(2):1673-1679. PubMed ID: 34562168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripherally inserted central venous catheter-associated bloodstream infections in hospitalized adult patients.
    Ajenjo MC; Morley JC; Russo AJ; McMullen KM; Robinson C; Williams RC; Warren DK
    Infect Control Hosp Epidemiol; 2011 Feb; 32(2):125-30. PubMed ID: 21460466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence, severity and outcome of central line related complications in pediatric oncology patients; A single center study.
    van den Bosch CH; van der Bruggen JT; Frakking FNJ; Terwisscha van Scheltinga CEJ; van de Ven CP; van Grotel M; Wellens LM; Loeffen YGT; Fiocco M; Wijnen MHWA
    J Pediatr Surg; 2019 Sep; 54(9):1894-1900. PubMed ID: 30415957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of microbial colonization rates between central venous catheters and peripherally inserted central catheters.
    Pitiriga V; Bakalis J; Theodoridou K; Dimitroulia E; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2023 Aug; 12(1):74. PubMed ID: 37550791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripherally Inserted Central Venous Catheter Complications in Children Receiving Outpatient Parenteral Antibiotic Therapy (OPAT).
    Kovacich A; Tamma PD; Advani S; Popoola VO; Colantuoni E; Gosey L; Milstone AM
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):420-4. PubMed ID: 26961677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation.
    Dandoy CE; Haslam D; Lane A; Jodele S; Demmel K; El-Bietar J; Flesch L; Myers KC; Pate A; Rotz S; Daniels P; Wallace G; Nelson A; Waters H; Connelly B; Davies SM
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1671-1677. PubMed ID: 27311966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan.
    Kato Y; Hagihara M; Kurumiya A; Takahashi T; Sakata M; Shibata Y; Kato H; Shiota A; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jan; 24(1):31-35. PubMed ID: 29066217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rates of Venous Thromboembolism and Central Line-Associated Bloodstream Infections Among Types of Central Venous Access Devices in Critically Ill Children.
    Patel N; Petersen TL; Simpson PM; Feng M; Hanson SJ
    Crit Care Med; 2020 Sep; 48(9):1340-1348. PubMed ID: 32590391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors.
    Ammann RA; Laws HJ; Schrey D; Ehlert K; Moser O; Dilloo D; Bode U; Wawer A; Schrauder A; Cario G; Laengler A; Graf N; Furtwängler R; Simon A
    Eur J Pediatr; 2015 May; 174(5):675-86. PubMed ID: 25804192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.